Cardiac disease in diabetic end-stage renal disease. - Wikidata - awgldk - TriplyDB

Cardiac disease in diabetic end-stage renal disease.

Cardiac disease in diabetic end-stage renal disease.

http://www.wikidata.org/entity/Q50920613

about

Nephropathy in type 2 diabetes.Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis Treatment of dyslipidemia in patients with type 2 diabetes.The anaemia of silent diabetic nephropathy-prevalence, physiopathology, and management.Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity.Anemia and diabetes.Diabetic nephropathy and anaemia.Landmark Prediction of Long Term Survival Incorporating Short Term Event Time Information Erythropoiesis-stimulating agents in kidney and cardiac disease.Association of glomerular filtration rate and inflammation with left ventricular hypertrophy in chronic kidney disease patients Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.Hemoglobin and overt nephropathy complications in type 1 diabetes.Oxidative stress in early diabetic nephropathy: fueling the fire.Cardiovascular risk in diabetic end-stage renal disease patients.Clinical impact of albuminuria in diabetic nephropathy.Chinese medicines in the treatment of experimental diabetic nephropathy.Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy.Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.Cigarette smoking: an important renal risk factor – far beyond carcinogenesis.Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients.rHuEPO dose inversely correlated with the number of circulating CD34+ cells in maintenance hemodialysis patients.Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes

P2860

Q33542374-DA4EC70E-7D71-4811-ADF8-B0A6A04CC648 Q33719168-3C3BC73F-C65B-4373-BBB6-6FE4AFD4F992 Q34499472-14A4FA99-ABD1-427D-9275-C2687AFC2813 Q35208122-33281100-7DF4-4898-B39F-33996EBE5817 Q35636784-2FC939BE-9634-4968-815B-77E4F7FE470F Q35903486-B05CDD0A-46CF-4E33-80A4-5EF1C6249DA7 Q36310912-B1B396ED-54E5-418F-A533-E5060398FA1A Q36503235-540822C1-8AA5-4ECB-B3B7-2D472C423E77 Q36636462-D3283762-42D4-41BF-98CA-C47DCB9DD3DF Q37082720-72B78D8E-3A17-4CC9-BB95-8ACFD072334E Q37087913-FDC6C383-8288-4D7C-8CA6-9DEFA8208DF0 Q37165278-767ADB04-5BD1-4B0C-AF05-0E402E7A27F4 Q37205471-656BD0A8-4F39-4CB8-8D88-73DA02743E28 Q37253710-F752F575-D6C3-4D0A-822F-F93A364102AC Q37820092-20CB9FC1-D252-4FF5-93D3-8ED7647FD39C Q37877789-9C2D6593-139C-4EF5-8B00-B9F9868E5CFB Q37914761-6263F0DF-A6C4-49FE-89E9-A965AEF9567E Q38609767-F89759CC-6BF3-44A8-8715-BAFE70D1F36F Q44558885-9D77DA2C-CA77-4882-BFA9-14E258513339 Q45249858-DB0C4673-A095-46B7-AEE6-380D77DF22C6 Q46661747-05017AF5-EA54-4915-BF48-582F38615269 Q51755409-B1C3FB49-D835-44C2-84A9-457E43FBF1AF Q53510308-63D624DF-69E4-4223-AAD1-9D425C32234E Q57649306-67F91C3D-AD84-4E02-9FA3-A29EDD9FB210

P2860

Cardiac disease in diabetic end-stage renal disease.

http://www.wikidata.org/entity/Q50920613

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Cardiac disease in diabetic end-stage renal disease.

@en

Cardiac disease in diabetic end-stage renal disease.

@nl

type

label

Cardiac disease in diabetic end-stage renal disease.

@en

Cardiac disease in diabetic end-stage renal disease.

@nl

prefLabel

Cardiac disease in diabetic end-stage renal disease.

@en

Cardiac disease in diabetic end-stage renal disease.

@nl

P1433

Q50920613-C8E85DE5-DD09-4590-9B57-150C32B7C161

P1476

Q50920613-5AB3CBCE-416A-4BE3-92AC-E4095692DFA0

P2093

Q50920613-72C25267-1A81-4B0F-87A1-A398C0AD828A

Q50920613-829436D4-933C-4EE1-B414-BEB0C4FDC0A1

Q50920613-A082E645-224E-41D4-B234-6CFE0FF7DC72

Q50920613-A1EF020C-F835-4940-B685-B09250D14FB5

Q50920613-E445CF37-60CF-48F6-9E6C-B961EC4517FC

Q50920613-ED1C4F44-C8ED-427C-A11C-28180147B722

Q50920613-F97785BA-99FB-4127-8824-ABFC3E90F0C1

P2860

Q50920613-0B9A3204-2AF7-4AAE-8D24-9DFFE6D4D042

Q50920613-27F89E7B-5618-4A05-8C20-64A5E68C6093

Q50920613-2F638D0C-1034-4C06-8830-CD45AE4A08E0

Q50920613-4A9745CE-0491-4D91-9511-0EC485E571C6

Q50920613-4EAB855D-D7DD-4C1D-B67E-15C237205FBC

Q50920613-56C362C5-6A8F-4E56-9E5B-2FCF7058A5E7

Q50920613-7B7F18D2-1FF0-4F7C-B25A-BBD0637415AC

Q50920613-865667BC-FECC-49C0-ACDD-37F350F3F5EE

Q50920613-8DFF24BA-7B2F-477B-ADF0-C5530BA31C29

Q50920613-9565B81C-7C5C-4E6C-A4E6-F232F70E5D3D

P2888

Q50920613-C88A80FE-CA19-4314-BD01-53AFB9969362

P304

Q50920613-072DB74E-E45A-4A94-AF7B-993AD216032D

P31

Q50920613-E704A50E-B32A-440B-A4A9-953D6F5D3EDA

P356

Q50920613-D55FDF4D-A006-4873-983F-2A03F09708C4

P433

Q50920613-87A3CB8C-E4C2-4353-886F-4611823D203F

P478

Q50920613-2FD9C933-4FEB-4D1C-B38F-B21EB984018D

P577

Q50920613-5AA1991B-F0CD-49F6-8251-D0A748866C44

P5875

Q50920613-E7A16D35-DF77-45CB-B4E6-2489BA0D42DF

P698

Q50920613-71D71192-1D7D-4BDF-97D0-017F83F3ECB6

P356

P1433

P1476

Cardiac disease in diabetic end-stage renal disease.

@en

P2093

B F Culleton

http://www.w3.org/2001/XMLSchema#string

D C Murray

http://www.w3.org/2001/XMLSchema#string

G M Kent

http://www.w3.org/2001/XMLSchema#string

J D Harnett

http://www.w3.org/2001/XMLSchema#string

P E Barre

http://www.w3.org/2001/XMLSchema#string

P S Parfrey

http://www.w3.org/2001/XMLSchema#string

R N Foley

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of renal replacement treatment in patients with diabetes mellitus.

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.

Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities.

Left ventricular function in diabetes mellitus. II: Relation between clinical features and left ventricular function

Diabetes and cardiovascular disease. The Framingham study.

Role of diabetes in congestive heart failure: the Framingham study.

End-stage renal disease attributable to diabetes mellitus.

Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus.

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.

P2888

P304

1307-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S001250050825

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1997-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13841490

http://www.w3.org/2001/XMLSchema#string

P698

9389423

http://www.w3.org/2001/XMLSchema#string